474 related articles for article (PubMed ID: 17443674)
1. Dual regulation of upstream binding factor 1 levels by IRS-1 and ERKs in IGF-1-receptor signaling.
Sun H; Tu X; Liu M; Baserga R
J Cell Physiol; 2007 Sep; 212(3):780-6. PubMed ID: 17443674
[TBL] [Abstract][Full Text] [Related]
2. A mechanism for cell size regulation by the insulin and insulin-like growth factor-I receptors.
Sun H; Tu X; Baserga R
Cancer Res; 2006 Dec; 66(23):11106-9. PubMed ID: 17145851
[TBL] [Abstract][Full Text] [Related]
3. Transformation by the simian virus 40 T antigen is regulated by IGF-I receptor and IRS-1 signaling.
DeAngelis T; Chen J; Wu A; Prisco M; Baserga R
Oncogene; 2006 Jan; 25(1):32-42. PubMed ID: 16170362
[TBL] [Abstract][Full Text] [Related]
4. Deletion of the pleckstrin and phosphotyrosine binding domains of insulin receptor substrate-2 does not impair its ability to regulate cell proliferation in myeloid cells.
Sun H; Baserga R
Endocrinology; 2004 Nov; 145(11):5332-43. PubMed ID: 15297443
[TBL] [Abstract][Full Text] [Related]
5. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
[TBL] [Abstract][Full Text] [Related]
6. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins.
Dews M; Nishimoto I; Baserga R
Recept Signal Transduct; 1997; 7(4):231-40. PubMed ID: 9633824
[TBL] [Abstract][Full Text] [Related]
7. IRS-2, but not IRS-1, can sustain proliferation and rescue UBF stabilization in InR or InR defective signaling of 32D myeloid cells.
Wu S; Zhou B; Xu L; Sun H
Cell Cycle; 2009 Oct; 8(19):3218-26. PubMed ID: 19738441
[TBL] [Abstract][Full Text] [Related]
8. Prolonged vs transient roles for early cell cycle signaling components.
Rose DW; Xiao S; Pillay TS; Kolch W; Olefsky JM
Oncogene; 1998 Aug; 17(7):889-99. PubMed ID: 9780005
[TBL] [Abstract][Full Text] [Related]
9. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
[TBL] [Abstract][Full Text] [Related]
10. Expression profiles of micro RNA in proliferating and differentiating 32D murine myeloid cells.
Shi B; Prisco M; Calin G; Liu CG; Russo G; Giordano A; Baserga R
J Cell Physiol; 2006 Jun; 207(3):706-10. PubMed ID: 16482530
[TBL] [Abstract][Full Text] [Related]
11. Role of pescadillo and upstream binding factor in the proliferation and differentiation of murine myeloid cells.
Prisco M; Maiorana A; Guerzoni C; Calin G; Calabretta B; Voit R; Grummt I; Baserga R
Mol Cell Biol; 2004 Jun; 24(12):5421-33. PubMed ID: 15169904
[TBL] [Abstract][Full Text] [Related]
12. Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines.
Jackson JG; Zhang X; Yoneda T; Yee D
Oncogene; 2001 Nov; 20(50):7318-25. PubMed ID: 11704861
[TBL] [Abstract][Full Text] [Related]
13. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.
Oesterreich S; Zhang P; Guler RL; Sun X; Curran EM; Welshons WV; Osborne CK; Lee AV
Cancer Res; 2001 Aug; 61(15):5771-7. PubMed ID: 11479214
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of the upstream binding factor1 by glycogen synthase kinase3beta in myeloid cells induced to differentiate.
Liu M; Tu X; Ferrari-Amorotti G; Calabretta B; Baserga R
J Cell Biochem; 2007 Apr; 100(5):1154-69. PubMed ID: 17063482
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration.
Cui X; Kim HJ; Kuiatse I; Kim H; Brown PH; Lee AV
Cancer Res; 2006 May; 66(10):5304-13. PubMed ID: 16707456
[TBL] [Abstract][Full Text] [Related]
16. Activation of insulin-like growth factor I receptor signaling pathway is critical for mouse plasma cell tumor growth.
Li W; Hyun T; Heller M; Yam A; Flechner L; Pierce JH; Rudikoff S
Cancer Res; 2000 Jul; 60(14):3909-15. PubMed ID: 10919668
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-1 induces rapid tyrosine phosphorylation of the vav proto-oncogene product.
Uddin S; Yetter A; Katzav S; Hofmann C; White MF; Platanias LC
Exp Hematol; 1996 Apr; 24(5):622-7. PubMed ID: 8605967
[TBL] [Abstract][Full Text] [Related]
18. The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase.
Martin MJ; Melnyk N; Pollard M; Bowden M; Leong H; Podor TJ; Gleave M; Sorensen PH
Mol Cell Biol; 2006 Mar; 26(5):1754-69. PubMed ID: 16478996
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor I receptor signaling and nuclear translocation of insulin receptor substrates 1 and 2.
Sun H; Tu X; Prisco M; Wu A; Casiburi I; Baserga R
Mol Endocrinol; 2003 Mar; 17(3):472-86. PubMed ID: 12554758
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of feedback regulation of insulin receptor substrate-1 phosphorylation in primary adipocytes.
Hers I; Tavaré JM
Biochem J; 2005 Jun; 388(Pt 2):713-20. PubMed ID: 15713122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]